Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (kp Pharma) have decided to invest 5 million Euro for enhancing the capacity of their Cotia, Brazil facility. kp Pharma plans to manufacture new products in the region with the help of expanded capacity at its Brazilian location.
“We are seeing substantial growth in our high barrier product segments in South America in response to the increased temperature, moisture, and oxygen sensitivity of new drugs. We are excited to support this key mega-trend by adding significant capacity and technical capability to support new products into our Cotia facility”, said Tracey Peacock, President, Pharmaceutical & Medical Device Films at kp.
He, added, “This latest investment comes about 2 years after the addition of the fourth slitting line in Cotia, which increased the current site’s slitting capacity by ~4.000 tons per year. We expect the new capability to be operational from July 2019 with the simple aim of improving service to our customers wherever they are located in the South American region.”
The company will showcase its products and capabilities to customers in upcoming FCE Pharma trade show in São Paulo, Brazil.
Klöckner Pentaplast Group, a global leader in rigid and flexible packaging, printing and specialty solutions, serves the pharmaceutical, medical device, food, beverage and card markets.
Klöckner Pentaplast’s portfolio includes packaging, films, and services playing an integral role in its customers’ value chains, safeguarding product integrity, assuring safety and consumer health.
The company is keen to improve sustainability and thereby protect brand reputation. Founded in 1965, Klöckner Pentaplast has its footprints in 18 countries with over 6,300 people serving customers worldwide from 61 locations, including 32 production sites.